Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes Medical Dialogues Bureau21 Sept 2019 9:30 AM IST"We are delighted that the findings of the CONCLUDE trial support what we have seen previously across the Tresiba clinical development programme,"...